Surely a positive outcome of the covid trial would also have a positive impact? There would be a huge worldwide demand, especially in countries where vaccine programs have yet to pick up momentum. And covid is not going away. It's here to stay, like influenza. We'll need both vaccines and drugs forever. And if ABL reduces infection by suppressing ACE2 receptors, it might be valuable as a prophylactic.